SNMMI concerned about oncology coverage guidelines

The Society of Nuclear Medicine and Molecular Imaging expressed their concern with an updated list of oncology coding recommendations released by eviCore, a benefits management company.

eviCore will no longer cover vluiciclovinem, choline or GA DOTATE for PET imaging, citing that the scans are "considered investigational and experimental for all indications for prostate cancer at this time." SNMMI will continue to follow the issue and is working with patient advocay groups to formulate a response.

Follow the link below to learn more about these updated coverage guidelines:

As a Senior Writer for TriMed Media Group, Will covers radiology practice improvement, policy, and finance. He lives in Chicago and holds a bachelor’s degree in Life Science Communication and Global Health from the University of Wisconsin-Madison. He previously worked as a media specialist for the UW School of Medicine and Public Health. Outside of work you might see him at one of the many live music venues in Chicago or walking his dog Holly around Lakeview.

Around the web

The ACR hopes these changes, including the addition of diagnostic performance feedback, will help reduce the number of patients with incidental nodules lost to follow-up each year.

And it can do so with almost 100% accuracy as a first reader, according to a new large-scale analysis.

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.